Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref.
studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results deaths Eclinical improvement Edeath or ventilation E

COVID-19 meta-analysis

Wu, 2020 OBScorticosteroidscontrolCOVID-19serious
-/- suggested -56%

COVID 19 hospitalized meta-analysis

Ranjbar, 2021
  IRCT20200204046369N1		 RCTmethylprednisolonedexamethasoneCOVID 19 hospitalizedsome concern
44/42 suggested -54%
GLUCOCOVID, 2020 RCTcorticosteroidscontrolCOVID 19 hospitalizedhigh
34/29 suggested
Metcovid, 2020
  NCT04343729		 RCTmethylprednisoloneplaceboCOVID 19 hospitalizedsome concern
209/207 inconclusive -7%
RECOVERY dexamethasone, 2020
  NCT04381936		 RCTdexamethasonestandard of careCOVID 19 hospitalizedsome concern
2104/4321 conclusif demonstrated-15% -7%
Fernández Cruz, 2020 OBScorticosteroidsstandard of careCOVID 19 hospitalizedserious
396/67 suggested -59%

COVID 19 all comers meta-analysis

Tang X, 2020
  NCT04273321		 RCTmethylprednisoloneplaceboCOVID 19 all comerssome concern
43/43 inconclusive -2%

COVID-19 severe or critically meta-analysis

CAPE-COVID, 2020
  NCT02517489		 RCTHydrocortisoneplaceboCOVID-19 severe or criticallylow
76/73 inconclusive -50% -26%
CODEX (Tomazini), 2020
  NCT04327401		 RCTdexamethasonestandard of careCOVID-19 severe or criticallysome concern
151/148 inconclusive -3%
COVID STEROID, 2020
  NCT04348305		 RCTcorticosteroidsplaceboCOVID-19 severe or criticallylow
15/14 inconclusive 270%
DEXA-COVID19, 2020
  NCT04325061		 RCTdexamethasonestandard of careCOVID-19 severe or criticallylow
7/12 inconclusive 90%
Edalatifard, 2020
  IRCT20200404046947N1		 RCTmethylprednisolonestandard of careCOVID-19 severe or criticallyhigh
34/34 suggested -64% 990%
REMAP-CAP, fixed 7-day course, 2020
  NCT02735707		 RCTHydrocortisonestandard of careCOVID-19 severe or criticallysome concern
143/108 inconclusive -5% 39%
REMAP-CAP, shock-dependent course, 2020
  NCT02735707		 RCTcorticosteroidsstandard of careCOVID-19 severe or criticallysome concern
152/108 inconclusive -2% 20% 22%
Steroids-SARI, 2020
  NCT04244591		 RCTmethylprednisolonestandard of careCOVID-19 severe or criticallysome concern
24/23 inconclusive -8%
Jianfeng, 2020 OBScorticosteroidsstandard of careCOVID-19 severe or criticallyserious
-/- safety concern 165%
Raef, 2020 OBScorticosteroidsstandard of careCOVID-19 severe or criticallycritical
-/- suggested -50%
Lu, 2020 OBScorticosteroidscontrolCOVID-19 severe or criticallyserious
151/93 inconclusive 206%

PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons